All Biotech News

List of articles in category All Biotech News
Title	Published Date
Molecular Devices and MIMETAS Present New Turnkey Solution for Organ-On-A-Chip Market	02/06/2017
Rentschler and Leukocare Announce Strategic Alliance And Equity Investment	02/02/2017
Agendia Co-Founder Laura van ’t Veer Wins European Cancer Organization Clinical Research Award	01/30/2017
Vetter Starts Operations in Its Center for Visual Inspection and Logistics	01/25/2017
Sartorius Stedim Biotech Supports Mainstream Adoption of Quality by Design	01/18/2017
Selonterra Publishes Novel Proprietary Mechanism for APOE4 in Alzheimer’s Disease	01/17/2017
leon-nanodrugs Partners with Bionpharma for Development Of a MicroJet Reactor (MJR®) Based Dermatological Product	01/16/2017
A-SKIN Secures Patent for Groundbreaking Skin Engineering Therapy with Wound Healing Formulation® (WHF) Facilitating the Natural Human Wound Healing Process	01/13/2017
Shuwen Biotech Receives EN ISO 13485 Certification	01/13/2017
RedHill Biopharma Announces QIDP Fast-Track Designation Granted by FDA to RHB-104 for Nontuberculous Mycobacteria Infections	01/11/2017
RedHill Biopharma Announces First Dosing in RHB-105 Supportive PK Studies Ahead of Confirmatory Phase III Study for H. pylori Infection	01/10/2017
Orchard Therapeutics Ltd. Announces a Manufacturing Alliance with PharmaCell B.V.	01/09/2017
leon-nanodrugs GmbH Appoints Pharma Expert Michael Mehler as Chief Executive Officer	01/09/2017
Hookipa Biotech Announces Publication in Clinical and Vaccine Immunology Highlighting Vaxwave® as an Effective Viral Vector for Vaccination against Congenital Cytomegalovirus Infections	01/09/2017
RedHill Biopharma Announces YELIVA® (ABC294640) Abstract Presentation at the 2017 Cholangiocarcinoma Foundation Annual Conference	01/06/2017
HUB and Dutch Health Insurance Companies to Validate Use of Organoids for Cystic Fibrosis	01/06/2017
Xigen’s Brimapitide, an Innovative JNK Inhibitor, Delivers Positive Phase II Results in Inflammatory Eye Disease	01/05/2017
RedHill Biopharma Announces Exclusive U.S. Co-Promotion Agreement with Concordia for GI Drug Donnatal®	01/03/2017
New Data Shows that MammaPrint® Substantially Impacts How Breast Cancer Patients in Germany are Treated	12/21/2016
bluebird bio and apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement	12/15/2016
RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT® for Migraines with Pharmatronic Co. in South Korea	12/14/2016
Three New Studies Presented at San Antonio Breast Cancer Symposium Further Demonstrate Value of MammaPrint® and BluePrint® in Individualizing Treatment for Breast Cancer Patients	12/14/2016
Acousia Therapeutics Receives EUR 2.5 Million to Develop Innovative Therapy to Treat and Prevent Sensorineural Hearing Loss	12/14/2016
Vetter's Skokie Site Successfully Manufactures Batches on New Clinical Syringe Filling Line	12/13/2016
RedHill Biopharma Announces Positive and Unanimous DSMB Recommendation for Continuation of Phase III Study with RHB-104 for Crohn's Disease	12/13/2016
RedHill Biopharma Announces Phase IIa 48-Week Final Results Further Supporting Potential of RHB-104 in Multiple Sclerosis	12/12/2016
New Flash Cartridges for Peptide Purification from Biotage	12/07/2016
LifeCodexx Receives CE Mark for its Novel NIPT Solution Based On Methylation-Specific Quantitative PCR	12/07/2016
leon-nanodrugs Partners with Instillo for GMP Production of a MicroJet Reactor (MJR®) Based Formulation of a Generic Oncology Supportive Product	12/07/2016
Neurimmune and TVM Capital Life Science Announce Creation of AL-S Pharma to Develop Innovative Therapy for Patients with ALS	12/07/2016

Page 39 of 84